Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial
Publicado en: | Nature Cancer 4(2023)1, S. 96-107 |
---|---|
VerfasserIn: | Denkinger, Claudia M. (VerfasserIn), Janssen, Maike (VerfasserIn), Pohle, Thorsten (VerfasserIn), Ruhe, Matthias (VerfasserIn) |
Formato: | Artigo |
Idioma: | English |
Publicado: |
2023
|
Schlagworte: | |
Acceso en liña: | https://doi.org/10.1038/s43018-022-00503-w |
Títulos relacionados: | In:
Nature Cancer |
Títulos similares
-
Phenobarbitalintoxikation in suizidaler Absicht : kontinuierliche venovenöse Hämodialyse als effektive Therapie
por: Ruhe, Matthias, et al.
Publicado: (2016) -
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders : a cohort study from Germany
por: Kümpfel, Tania, et al.
Publicado: (2020) -
Impact of physical or sexual childhood abuse on plasma DHEA, DHEA-S and cortisol in a low-dose dexamethasone suppression test and on cardiovascular risk parameters in adult patients with major depression or anxiety disorders
por: Kellner, Michael, et al.
Publicado: (2018) -
Transiente globale Amnesie und Tako-Tsubo-Kardiomyopathie - Zufall oder logische Folge?
por: Grautoff, Steffen, et al.
Publicado: (2012) -
Effects of 35% carbon dioxide (CO 2) inhalation in patients with post-traumatic stress disorder (PTSD) : a double-blind, randomized, placebo-controlled, cross-over trial
por: Kellner, Michael, et al.
Publicado: (2018)